Regeneron Pharmaceuticals, Inc. (REGN) Analyst Forecast

NASDAQ Currency in USD Disclaimer

Stock Price

$755.17

$11.82

(1.59%)

Day's range

$735.95

$757.56

Consensus Rating

Hold

Based on 28 Analyst Ratings
Consensus Price Target

$995.63

31.84% Upside

Recent Analyst Forecasts and Stock Ratings

Date	Brokerage Firm	Analyst Name	Price Target	Price when Posted	Upside/Downside on Report Date
11/01/2024	BMO Capital	Evan David Seigerman	$1,190.00	$843.60	41.06%
11/01/2024	Piper Sandler	Christopher Raymond	$1,195.00	$843.60	41.65%
11/01/2024	Leerink Partners	Andrew Berens	$880.00	$843.60	4.31%
10/31/2024	Evercore ISI	Cory Kasimov	$1,170.00	$838.20	39.58%
10/24/2024	Evercore ISI	Cory Kasimov	$1,175.00	$941.39	24.82%
10/23/2024	Wells Fargo	Mohit Bansal	$1,050.00	$962.34	9.11%
09/24/2024	Truist Financial	Thomas Klee	$1,200.00	$1,091.98	9.89%
09/24/2024	Leerink Partners	David Risinger	$1,077.00	$1,091.98	-1.37%
09/24/2024	Robert W. Baird	Brian Skorney	$940.00	$1,091.98	-13.92%
09/24/2024	Goldman Sachs	Salveen Richter	$1,292.00	$1,091.98	18.32%
09/12/2024	BMO Capital	Evan David Seigerman	$1,300.00	$1,159.95	12.07%
09/09/2024	RBC Capital	Brian Abrahams	$1,282.00	$1,139.41	12.51%
08/23/2024	Raymond James	Christopher Raymond	$1,242.00	$1,187.66	4.58%
08/02/2024	Bank of America Securities	Geoff Meacham	$805.00	$1,077.48	-25.29%
08/02/2024	RBC Capital	Brian Abrahams	$1,240.00	$1,093.14	13.43%
07/19/2024	Raymond James	Christopher Raymond	$1,166.00	$1,063.60	9.63%
07/18/2024	Guggenheim	Yatin Suneja	$1,180.00	$1,085.62	8.69%
07/12/2024	UBS	Trung Huynh	$1,250.00	$1,092.31	14.44%
07/11/2024	Morgan Stanley	Terence Flynn	$1,182.00	$1,071.12	10.35%
06/25/2024	Argus Research	Jasper Hellweg	$1,170.00	$1,063.89	9.97%
06/13/2024	RBC Capital	Brian Abrahams	$1,299.00	$1,022.03	27.1%
06/12/2024	RBC Capital	Brian Abrahams	$1,229.00	$1,010.54	21.62%
06/04/2024	RBC Capital	Brian Abrahams	$1,200.00	$998.64	20.16%
06/03/2024	BMO Capital	Evan David Seigerman	$1,082.00	$992.47	9.02%
05/20/2024	Raymond James	Christopher Raymond	$1,000.00	$982.29	1.8%
05/13/2024	Evercore ISI	Cory Kasimov	$1,150.00	$976.96	17.71%
05/03/2024	RBC Capital	Brian Abrahams	$1,185.00	$937.61	26.39%
04/12/2024	Jefferies	Akash Tewari	$1,060.00	$911.78	16.26%
04/11/2024	RBC Capital	Brian Abrahams	$1,189.00	$921.34	29.05%
03/13/2024	Morgan Stanley	Matthew Harrison	$1,115.00	$965.47	15.49%
01/12/2024	BMO Capital	Brian Abrahams	$1,076.00	$934.06	15.2%
01/12/2024	RBC Capital	Brian Abrahams	$1,076.00	$933.20	15.3%
03/27/2023	Leerink Partners	Andrew Berens	$976.00	$820.00	19.02%
03/23/2023	Jefferies	Akash Tewari	$925.00	$819.68	12.85%
09/09/2022	Morgan Stanley	Matthew Harrison	$851.00	$708.85	20.05%
09/08/2022	Jefferies	Akash Tewari	$675.00	$708.85	-4.78%
05/22/2022	Credit Suisse	Lorenzo Biasio	$725.00	$681.91	6.32%
02/03/2022	RBC Capital	Kennen MacKay	$679.00	$622.96	9%
02/03/2022	Cowen & Co.	Tyler Van Buren	$640.00	$622.96	2.74%
02/03/2022	J.P. Morgan	Cory Kasimov	$604.00	$622.96	-3.04%
02/01/2022	Evercore ISI	Joshua Schimmer	$680.00	$622.85	9.18%
01/17/2022	Morgan Stanley	Matthew Harrison	$585.00	$611.22	-4.29%
01/02/2022	Bernstein	Aaron Gal	$660.00	$627.10	5.25%
12/05/2021	Goldman Sachs	Salveen Richter	$824.00	$625.00	31.84%
11/09/2021	Cantor Fitzgerald	Alethia Young	$760.00	$622.20	22.15%
09/08/2021	UBS	Esther Rajavelu	$763.00	$646.11	18.09%
06/13/2021	Argus Research	Jasper Hellweg	$590.00	$528.75	11.58%
05/20/2021	Canaccord Genuity	John Newman	$700.00	$506.72	38.14%

Regeneron Pharmaceuticals, Inc. Frequently Asked Questions

What analysts cover Regeneron Pharmaceuticals, Inc.?

Regeneron Pharmaceuticals, Inc. has been rated by research analysts at BMO Capital, Piper Sandler, Leerink Partners, Evercore ISI, Wells Fargo, Truist Financial in the past 90 days.

Get The App

Regeneron Pharmaceuticals, Inc. (REGN) Analyst Forecast

Consensus Rating

Consensus Price Target

Recent Analyst Forecasts and Stock Ratings

Regeneron Pharmaceuticals, Inc. Frequently Asked Questions

What analysts cover Regeneron Pharmaceuticals, Inc.?

Select an alert type

Setup alert

Premium Content

Log In

Email Verification

Welcome to Stocks.News!

Create Your Account

Email Verification